Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:
- Conditions
- Pancreas Disease
- Registration Number
- NCT06135233
- Brief Summary
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
- Detailed Description
The European registry for Minimally Invasive Pancreatic Surgery (E-MIPS) is an E-AHPBA endorsed registry with the aim to monitor and safeguard the introduction of MIPD in Europe. International multicenter audit-based studies focusing on outcomes of minimally invasive pancreatoduodenectomy (MIPD) are lacking.
A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1336
- Data from all patients who underwent R-MIPD and L-MIPD between January 1st 2019 and December 31st 2021 were included
- Other pancreatic procedures
- Hybrid approaches (reconstruction phase open)
- Procedures with insufficient baseline data / missing primary outcome data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30-day/in-hospital mortality. 30 days Major morbidity 30 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Amsterdam UMC, locatie AMC
🇳🇱Amsterdam, Noord-Holland, Netherlands